Capital Flow Monitor · Sponsors · CIK 2088831
Kayak Therapeutics, Inc.
3317 BOWMAN AVENUE, AUSTIN, TX, 78703 · 917.892.9996
Biotechnology · Corporation· inc. DELAWARE true 2025
Fit score
—
Offering
$30.0M
Sold
$25.0M
% sold
83.3%
Investors
137
Min investment
$0
Exemption
506(b)
Filing history
| Filed | Form | Rule | Offering | Sold | % sold | Investors | |
|---|---|---|---|---|---|---|---|
| 2026-08-21 | D/A ·current | 506(b) | $30.0M | $25.0M | 83.3% | 137 | EDGAR ↗ |
| 2026-05-27 | D | 506(b) | $25.0M | $11.9M | 47.8% | 55 | EDGAR ↗ |
| 2025-09-29 | D | 506(b) | $10.0M | $6.6M | 66.3% | 42 | EDGAR ↗ |
Related persons
Executive officers, directors and promoters, as filed. Other raises are matched by exact name and show amount sold as last reported.
- Josiah Hornblower — Executive Officer / Director, Austin, TX
-
Tyler Brous — Director, Austin, TX
4 other raises
- BBK Cesium I SPV, LLC $7.1M of $7.1M · 100.0%
- BBK Ventures Fund I, LP $87.5M of $100.0M · 87.5%
- LCP Quantum Partners VI, LLC $6.4M of $6.4M · 100.0%
- ColdQuanta, Inc. $7.5M of $7.5M · 100.0%
- Conor Richardson — Executive Officer, Austin, TX
- Taylor Schreiber — Director, Austin, TX
Placement agents
- No sales compensation reported — direct raise.
Source: SEC EDGAR Form D. Self-reported by the issuer. Not investment advice.